Form 4 for PCRX Pacira BioSciences, Inc.
Accepted 2022-03-01 00:00:00 ET · period of report 2022-02-28 · accession 0001209191-22-014267 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-01 | 2022-02-28+ | PCRX | PACE GARY W | Dir | S - Sale+OE | $66.87 | -30.0K | 129.5K | -19% | -$2.01M |
| DM | 2022-03-01 | 2022-02-28+ | PCRX | PACE GARY W | Dir | M - OptEx | $11.02 | +30.0K | 139.3K | +27% | +$330.6K |
| DM | 2022-03-01 | 2022-02-28+ | PCRX | PACE GARY W | Dir | M - OptEx | $0.00 | -30.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-28 | S | D | 28,641 | $66.83 | 129,530 | D | — | — | (F1) he price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.750 to $67.155, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| 2 | Common | Common Stock | 2022-03-01 | M | A | 193 | $11.02 | 129,723 | D | — | — | |
| 3 | Common | Common Stock | 2022-03-01 | M | A | 1,166 | $11.02 | 130,889 | D | — | — | |
| 4 | Common | Common Stock | 2022-02-28 | M | A | 18,834 | $11.02 | 158,171 | D | — | — | |
| 5 | Common | Common Stock | 2022-02-28 | M | A | 9,807 | $11.02 | 139,337 | D | — | — | |
| 6 | Common | Common Stock | 2022-03-01 | S | D | 1,359 | $67.75 | 129,530 | D | — | — | |
| 7 | Derivative | Stock Option (Right to Buy) | 2022-02-28 | M | D | 9,807 | $0.00 | 193 | D | $11.02 · — to 2022-04-02 | 9,807 Common Stock | (F2) The stock option vested and became exercisable in twelve equal monthly installments, with the first installment being on May 3, 2012. |
| 8 | Derivative | Stock Option (Right to Buy) | 2022-03-01 | M | D | 1,166 | $0.00 | 0 | D | $11.02 · — to 2022-04-02 | 1,166 Common Stock | (F3) The option vested and became exercisable as to 25% of the option shares on April 3, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months. |
| 9 | Derivative | Stock Option (Right to Buy) | 2022-02-28 | M | D | 18,834 | $0.00 | 1,166 | D | $11.02 · — to 2022-04-02 | 18,834 Common Stock | (F3) The option vested and became exercisable as to 25% of the option shares on April 3, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months. |
| 10 | Derivative | Stock Option (Right to Buy) | 2022-03-01 | M | D | 193 | $0.00 | 0 | D | $11.02 · — to 2022-04-02 | 193 Common Stock | (F2) The stock option vested and became exercisable in twelve equal monthly installments, with the first installment being on May 3, 2012. |